Several studies point to high levels of S100B in AD patients (Marshak et al., 1992; Van Eldik and Griffin, 1994; Peskind et al., 2001; Petzold et al., 2003; Chaves et al., 2010) and in AD mouse models (Yeh et al., 2015). This evidence concerns the gene S100B and Alzheimer disease.